Jan 13, 2020 / 10:30PM GMT
Christopher Thomas Schott - JP Morgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott from JPMorgan and I'm joined by my colleague, Robbie Marcus, and we're very pleased to be hosting a fireside chat with J&J this afternoon. From J&J, we have Jennifer Taubert, Chairman of the Pharmaceutical division; as well as Ashley McEvoy, Chairman of Medical Devices.
Before we start, I did have to read an FD disclosure quickly here, and then we'll jump into questions. Please be aware, some of the statements we're making today may be considered forward-looking or utilize non-GAAP measures. Please refer to J&J's SEC filings, particularly the 10-K, which discusses the risks and uncertainties around such forward-looking statements as well as the website, investor.jnj.com, for reconciliations of comparable GAAP measures. Finally, any performance metrics today may represent results through and including the third quarter of 2019.
Johnson & Johnson at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers